Company Background and Services

PRIME exits and American Healthcare Capital are pleased to exclusively offer a media specialty company for sale that publishes clinical information for the cancer community. This visionary company has developed a unique, highly efficient platform for oncology related brands, who are operating in an increasingly competitive environment, to build awareness with patients and caregivers early in their healthcare journey. The proprietary, award-winning platform streamlines complex clinical diagnosis information, delivers visitors the ability to compare FDA-approved treatment options by cancer type and stage, and offers easy access to clinical trials as a potential treatment option. 

Since their launch in 2023, pharma and wellness companies have already invested marketing dollars in the platform to increase brand awareness. The company has grown quickly, generating $240,000 in contracts throughout 2024. The platform continues to gain momentum within the life science and cancer communities and anticipates accelerated growth in 2025 as a growing number of potential sponsors look for proven, high quality media opportunities.

Asking Price

The owner is looking for strategic investors with senior-level relationships within the pharma/cancer center/health media communities. They are seeking an investment of $1 million – $2 million to scale the business and build a direct sales organization with a robust marketing platform to accelerate growth. They are open to various deal structures.